|
1
|
Nauta JM, Roodenburg JL, Nikkels PG,
Witjes MJ and Vermey A: Comparison of epithelial dysplasia-the 4NQO
rat palate model and human oral mucosa. Int J Oral Maxillofac Surg.
24:53–58. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tang XH, Knudsen B, Bemis D, Tickoo S and
Gudas LJ: Oral cavity and esophageal carcinogenesis modeled in
carcinogen-treated mice. Clin Cancer Res. 10:301–313. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fisker AV, Philipsen HP and Overvad K:
Dose-response relationship in complete oral 4NQO-carcinogenesis in
rats. Acta Pathol Microbiol Immunol Scand A. 95:281–288.
1987.PubMed/NCBI
|
|
4
|
Jiang C, Ye D, Qiu W, Zhang X, Zhang Z, He
D, Zhang P and Chen W: Response of lymphocyte subsets and cytokines
to Shenyang prescription in Sprague-Dawley rats with tongue
squamous cell carcinomas induced by 4NQO. BMC Cancer. 7:402007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li J, Liang F, Yu D, Qing H and Yang Y:
Development of a 4-nitroquinoline-1-oxide model of lymph node
metastasis in oral squamous cell carcinoma. Oral Oncol. 49:299–305.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hayashida T, Jinno H, Kitagawa Y and
Kitajima M: Cooperation of cancer stem cell properties and
epithelial-mesenchymal transition in the establishment of breast
cancer metastasis. J Oncol. 2011:5914272011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nawshad A, LaGamba D and Hay ED:
Transforming growth factor beta (TGFbeta) signalling in palatal
growth, apoptosis and epithelial mesenchymal transformation (EMT).
Archiv Oral Biol. 4:675–689. 2004. View Article : Google Scholar
|
|
8
|
Massagué J, Blain SW and Lo RS: TGFbeta
signaling in growth control, cancer, and heritable disorders. Cell.
103:295–309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wheelock MJ and Johnson KR: Cadherins as
modulators of cellula phenotype. Annu Rev Cell Dev Biol.
19:207–235. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gravdal K, Halvorsen OJ, Haukaas SA and
Akslen LA: A switch from E-cadherin to N-cadherin expression
indicates epithelial to mesenchymal transition and is of strong and
independent importance for the progress of prostate cancer. Clin
Cancer Res. 13:7003–7011. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bargonetti J and Manfredi JJ: Multiple
roles of the tumor suppressor p53. Curr Opin Oncol. 14:86–91. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tokino T and Nakamura Y: The role of
p53-target genes in human cancer. Crit Rev Oncol Hematol. 33:1–6.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei H, Wei S, Gan B, Peng X, Zou W and
Guan JL: Suppression of autophagy by FIP200 deletion inhibits
mammary tumorigenesis. Genes Dev. 25:1510–1527. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lebovitz CB, Robertson AG, Goya R, Jones
SJ, Morin RD, Marra MA and Chandra B: Cross-cancer profiling of
molecular alterations within the human autophagy interaction
network. Autophagy. 11:1668–1687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei H, Wei S, Gan B, Peng X, Zou W and
Guan JL: Screening for microsatellite instability identifies
frequent 3′-untranslated region mutation of the RB1-inducible
coiled-coil 1 gene in colon tumors. PLoS One. 4:e77152009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schmidt-Kittler O, Ragg T, Daskalakis A,
Granzow M, Ahr A, Blankenstein TJ, Kaufmann M, Diebold J, Arnholdt
H, Muller P, et al: From latent disseminated cells to overt
metastasis: Genetic analysis of systemic breast cancer progression.
Proc Natl Acad Sci USA. 100:pp. 7737–7742. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Raica M, Cimpean AM and Ribatti D:
Angiogenesis in pre-malignant conditions. Eur J Cancer.
45:1924–1934. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Folkman J, Watson K, Ingber D and Hanahan
D: Induction of angiogenesis during the transition from hyperplasia
to neoplasia. Nature. 339:58–61. 1989. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jammal MP, Da Silva A, Filho AM, DE Castro
Côbo E, Adad SJ, Murta EF and Nomenili RS: Immunohistochemical
staining of tumor necrosis factor-α and interleukin-10 in benign
and malignant ovarian neoplasms. Oncol Lett. 9:979–983.
2015.PubMed/NCBI
|
|
21
|
Lu SL, Reh D, Li AG, Woods J, Corless CL,
Kulesz-Martin M and Wang XJ: Overexpression of transforming growth
factor beta1 in head and neck epithelia results in inflammation,
angiogenesis, and epithelial hyperproliferation. Cancer Res.
64:4405–4410. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hazan RB, Phillips GR, Qiao RF, Norton L
and Aaronson SA: Exogenous expression of N-cadherin in breast
cancer cells induces cell migration, invasion, and metastasis. J
Cell Biol. 148:779–790. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nguyen PT, Kudo Y, Yoshida M, Iizuka S,
Ogawa I and Takata T: N-cadherin expression is correlated with
metastasis of spindle cell carcinoma of head and neck region. J
Oral Pathol Med. 40:77–82. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakajima S, Doi R, Toyoda E, Tsuji S, Wada
M, Koizumi M, Tulachan SS, Ito D, Kami K, Mori T, et al: N-cadherin
expression and epithelial-mesenchymal transition in pancreatic
carcinoma. Clin Cancer Res. 10:4125–4133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoshinaga K, Inoue H, Utsunomiya T, Sonoda
H, Masuda T, Mimori K, Tanaka Y and Mori M: N-cadherin is regulated
by activin A and associated with tumor aggressiveness in esophageal
carcinoma. Clin Cancer Res. 10:5702–5707. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davidson B, Gotlieb WH, Ben-Baruch G,
Nesland JM, Bryne M, Goldberg I, Kopolovic J and Berner A:
E-cadherin complex protein expression and survival in ovarian
carcinoma. Gynecol Oncol. 79:362–371. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nishioka H, Hiasa Y, Hayashi I, Kitahori
Y, Konishi N and Sugimura M: Immunohistochemical detection of p53
oncoprotein in human oral squamous cell carcinomas and
leukoplakias: Comparison with proliferating cell nuclear antigen
staining and correlation with clinicopathological findings.
Oncology. 50:426–429. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suraneni MV, Moore JR, Zhang D, Badeaux M,
Macaluso MD, Digiovanni J, Kusewitt D and Tang DG: Tumor
suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate
cancer. Cell Cycle. 13:1798–1810. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei H and Guan JL: Pro-tumorigenic
function of autophagy in mammary oncogenesis. Autophagy. 8:129–131.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morselli E, Shen S, Ruckenstuhl C, Bauer
MA, Mariño G, Galluzzi L, Criollo A, Michaud M, Maiuri MC, Chano T,
et al: P53 inhibits autophagy by interacting with the human
orthologue of yeast Atg17, RB1CC1/FIP200. Cell Cycle. 10:2763–2769.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei H, Wei S, Gan B, Peng X, Zou W and
Guan JL: Suppression of autophagy by FIP200 deletion inhibits
mammary tumorigenesis. Genes Dev. 25:1510–1527. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
33
|
Bos R, van der Groep P, Greijer AE,
Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ and van
der Wall E: Levels of hypoxia-inducible factor-1alpha independently
predict prognosis in patients with lymph node negative breast
carcinoma. Cancer. 97:1573–1581. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aebersold DM, Burri P, Beer KT, Laissue J,
Djonov V, Greiner RH and Semenza GL: Expression of
hypoxia-inducible factor-1alpha: A novel predictive and prognostic
parameter in the radiotherapy of oropharyngeal cancer. Cancer Res.
61:2911–2916. 2001.PubMed/NCBI
|
